BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22991704)

  • 1. NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk.
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):356-7. PubMed ID: 22991704
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of genetic testing for risk of Alzheimer's disease.
    Kane RA; Kane RL
    N Engl J Med; 2009 Jul; 361(3):298-9. PubMed ID: 19605835
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's research. How to talk about Alzheimer's risk.
    Miller G
    Science; 2012 Aug; 337(6096):792. PubMed ID: 22903992
    [No Abstract]   [Full Text] [Related]  

  • 5. Disclosure of the genetic risk of Alzheimer's disease.
    Gordon SC; Landa D
    N Engl J Med; 2010 Jan; 362(2):181-2; author reply 182. PubMed ID: 20071713
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics. Once shunned, test for Alzheimer's risk headed to market.
    Couzin J
    Science; 2008 Feb; 319(5866):1022-3. PubMed ID: 18292309
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathological synergism between amyloid-beta and apolipoprotein E4--the most prevalent yet understudied genetic risk factor for Alzheimer's disease.
    Belinson H; Michaelson DM
    J Alzheimers Dis; 2009; 17(3):469-81. PubMed ID: 19363257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
    Huang Y
    Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One step closer to defining Alzheimer's causes. ApoE4 gene identified as possible target for drug therapy in Alzheimer's treatment.
    Duke Med Health News; 2012 Aug; 18(8):6. PubMed ID: 23029675
    [No Abstract]   [Full Text] [Related]  

  • 10. US government sets out Alzheimer's plan.
    Wadman M
    Nature; 2012 May; 485(7399):426-7. PubMed ID: 22622544
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain changes may develop early in people with Alzheimer's risk marker. Changes in brain activity appear to occur before amyloid plaques emerge in people with a form of the APOE4 gene.
    Duke Med Health News; 2011 Mar; 17(3):3. PubMed ID: 21476240
    [No Abstract]   [Full Text] [Related]  

  • 12. Virology. Alzheimer's risk factor also aids HIV.
    Youngsteadt E
    Science; 2008 Jun; 320(5883):1577. PubMed ID: 18566258
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's research. Stopping Alzheimer's before it starts.
    Miller G
    Science; 2012 Aug; 337(6096):790-2. PubMed ID: 22903991
    [No Abstract]   [Full Text] [Related]  

  • 14. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
    Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
    Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention in Alzheimer disease: The importance of APOE4 plus family history.
    Corder EH; Caskey J
    Neurology; 2009 Dec; 73(24):2054-5. PubMed ID: 20007523
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
    Huang Y
    Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade.
    Ophir G; Amariglio N; Jacob-Hirsch J; Elkon R; Rechavi G; Michaelson DM
    Neurobiol Dis; 2005 Dec; 20(3):709-18. PubMed ID: 15979312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaky memories: Impact of
    Li W; Lo EH
    J Cereb Blood Flow Metab; 2020 Sep; 40(9):1912-1914. PubMed ID: 32600092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
    Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.